000 05413cam a2200781 i 4500
005 20250919132325.0
006 m o d
007 cr |||||||||||
008 190918s2016 enk ob 001 0 eng
010 _a2015-041033
020 _a9781118924952 (ePub)
020 _a1118924959 (ePub)
020 _a9781118924976 (Adobe PDF)
020 _a1118924975 (Adobe PDF)
020 _z9781118912034 (pbk.)
020 _a9781118924938
020 _a1118924932
020 _a1118912039 (pbk.)
020 _a9781118912034 (pbk.)
029 1 _aDEBBG
_bBV043628907
029 1 _aDEBBG
_bBV043738112
035 _a(OCoLC)925785722
_z(OCoLC)943826450
035 _a(OCoLC)ocn925785722
039 9 _a201911051450
_bmurni
_c201911051427
_dmurni
_y09-18-2019
_zhafiz
_wUKM UBCM Wiley MARC (363 titles).mrc
_x79
040 _aDLC
_beng
_erda
_cDLC
_dNST
_dYDXCP
_dEBLCP
_dDG1
_dOCLCO
_dRECBK
_dCOO
_dOCLCF
_dDEBBG
_dKSU
042 _apcc
049 _aMAIN
050 0 0 _aRC848.F3
060 1 0 _aWI 700
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
082 0 0 _a616.3/62
_223
245 0 0 _aClinical dilemmas in non-alcoholic fatty liver disease /
_c[edited by] Roger Williams, Simon Taylor-Robinson.
264 1 _aChichester, West Sussex, UK ;
_aHoboken, NJ :
_bJohn Wiley & Sons Inc.,
_c2016.
300 _a1 online resource.
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
490 1 _aClinical Dilemmas (UK)
504 _aIncludes bibliographical references and index.
505 0 _aHype or harm from fatty liver disease? / Stephen H Caldwell and Curt Argo -- Worldwide problem / Geoffrey Farrell and Philip Newsome -- Is insulin resistance the key motive for NAFLD? / Desmond Johnston -- Progression to cirrhosis is more likely in children with NAFLD? / Anil Dhawan -- NAFLD as cause of cryptogenic cirrhosis? / Jay Lefkowitch -- Is NAFLD different in absence of metabolic syndrome? / Yusuf Yilmaz -- Occurrence of noncirrhotic HCC in NAFLD / Stephen Harrison and Dawn Torres -- Fibrosis progression molecular pathways all important? / Anna-Mae Diehl and Dr Wing-Kin Syn -- Can fatty liver of NAFLD be distinguished from that of alcoholic liver disease? / David Kleiner and Elizabeth Brunt -- Are inflammasomes and intestinal microbiota relevant in disease progression to NASH? / M. Bilal Siddiqui, M. Shadab Siddiqui and Arun Sanyal -- Can genetic influence in non-alcoholic fatty liver disease be ignored? / Quentin Anstee -- Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events? / Soo Lim -- Is there a best method for diagnosis of NAFLD? / Vlad Ratziu -- Choice of non-invasive blood tests and FibroScan / Massimo Pinzani and Manolis Tsocatzis -- Are the guidelines AASLD, IASL, EASL and BSG of help? / Jean-Francois Dufour -- How to choose from different imaging modalities and screening techniques / Hero Hussain -- Are the pros outweighed by the cons of obtaining a liver biopsy? / Simon Taylor-Robinson and Jeremy Cobbold -- Screening for NAFLD in high risk population / Nader Lessan -- Balancing calorie restriction, exercise and weight reduction / Nicholas Finer -- Should physicians be prescribing, or patients self-medicating with Orlistat, vitamin E, vitamin D, insulin antagonist, Trental and coffee? / Brent Neuschwander-Tetri and Haripriya Maddur -- Does improvement in hepatic steatosis have a significant favourable effect on the metabolic syndrome, including diabetes? / Jukka Westerbacka -- What are the dangers as well as the true benefits of bariatric surgery? / Andrew Jenkinson -- Liver transplantation : what can it offer? / Roger Williams -- Molecular antagonists, leptin or other hormones in supplementing environmental factors? / Jeremy Tomlinson -- Use of antifibrotic agents in clinical practice / Jonathan Fallowfield -- Better understanding of early development and material influence? / Jude Oben -- Defining the role of metabolic physician / Nicholas Finer.
588 _aDescription based on print version record and CIP data provided by publisher.
650 0 _aFatty Liver.
650 7 _aHEALTH & FITNESS
_xDiseases
_xGeneral.
_2bisacsh
650 7 _aMEDICAL
_xClinical Medicine.
_2bisacsh
650 7 _aMEDICAL
_xDiseases.
_2bisacsh
650 7 _aMEDICAL
_xEvidence-Based Medicine.
_2bisacsh
650 7 _aMEDICAL
_xInternal Medicine.
_2bisacsh
650 7 _aFatty liver.
_2fast
_0(OCoLC)fst00921974
650 2 _aNon-alcoholic Fatty Liver Disease.
655 4 _aElectronic books.
655 0 _aElectronic books.
700 1 _aWilliams, Roger,
_d1931-
_eeditor.
700 1 _aTaylor-Robinson, Simon D.,
_eauthor.
773 0 _tWiley e-books
776 0 8 _iPrint version:
_tClinical dilemmas in non-alcoholic fatty liver disease
_dChichester, West Sussex ; Hoboken, NJ : John Wiley & Sons Inc., 2016
_z9781118912034
_w(DLC) 2015040510
830 0 _aClinical Dilemmas (UK)
856 4 0 _uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=https://doi.org/10.1002/9781118924938
_zWiley Online Library
907 _a.b16755728
_b2022-10-11
_c2019-11-12
942 _n0
914 _avtls003651229
998 _ae
_b2019-05-09
_cm
_dz
_feng
_genk
_y0
_z.b16755728
999 _c643459
_d643459